Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination. NEMESIA (Non clEar MEtaStatic renal cell carcinoma pembrolIzumab Axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)
Axitinib;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination. NEMESIA (Non clEar MEtaStatic renal cell carcinoma pembrolIzumab Axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a) ### Output: Axitinib;Pembrolizumab